Review Article

Emerging Approaches of Transcatheter Valve Repair/Insertion

Table 1

Clinical characteristics of patients presenting for transcatheter aortic valve implantation.

TransfemoralTransapicalTransaxillary value

Patients 107 15 15
Edwards-Sapien, (%) 61 (57) 15 (100) 3 (20) .0001
CoreValve, (%) 46 (43) 12 (80) .0001
Age (years) 79.7 ± 7 78.8 ± 6.5 78.7 ± 5.794
Male, (%) 56 (52) 5 (33) 12 (80).034
Diabetes, (%) 31 (29) 4 (26.7) 5 (33).917
Chronic kidney disease, (%) 39 (36.4) 5 (33) 7 (46.7).706
Porcelain aorta, (%) 17 (15.9) 14 (93.3) 7 (46.7) .0001
COPD, (%) 46 (43) 6 (40) 11 (73).077
Previous myocardial infarction, (%) 29 (27) 5 (33) 6 (40).549
Cerebrovascular disease, (%) 20 (18.7) 8 (53) 3 (20).011
Peripheral vascular disease, (%) 26 (24.3) 10 (67.7) 12 (80) .0001
NYHA functional class III-IV, (%) 75 (70) 11 (73.3) 9 (60).685
Logistic EuroSCORE, mean ± SD 26.6 ± 16 32.2 ± 23 28.6 ± 14.477
STS-PROM score, mean ± SD 7 ± 4.9 8.3 ± 4.2 6.9 ± 2.8.602
Mean aortic gradient (mmHg), mean ± SD 54 ± 17.2 44.7 ± 18 47.7 ± 14.9.074
LVEF (%), mean ± SD 50.8 ± 12.9 50 ± 12.5 52.8 ± 11.814

COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LVEF: left ventricle ejection fraction.